Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Tourette Syndrome

1-(3-chlorophenyl)piperazine has been researched along with Tourette Syndrome in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Tourette Syndrome: A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cath, DC1
Gijsman, HJ1
Schoemaker, RC1
van Griensven, JM1
Troost, N1
van Kempen, GM1
Cohen, AF1

Trials

1 trial available for 1-(3-chlorophenyl)piperazine and Tourette Syndrome

ArticleYear
The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome.
    Psychopharmacology, 1999, Volume: 144, Issue:2

    Topics: Adult; Aged; Compulsive Behavior; Cross-Over Studies; Double-Blind Method; Female; Humans; Impulsive

1999